Octreotide 500micrograms/1ml solution for injection vials
BNF presentation 0803043N0AAAMAM within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0803043N0AAAMAM
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
24
NHS spend (£)
£11,630.17
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 6 |
| November 2024 | 4 |
| August 2024 | 1 |
| July 2024 | 5 |
| May 2024 | 1 |
| July 2021 | 2 |
| December 2020 | 4 |
| November 2020 | 1 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 2 | No data available |
|
Eynsham Medical Group
ODS K84006
|
2 | 10Q - BUCKS,OXFORDSHIRE & BERKS WEST ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |